Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency

Frank P. Mockenhaupt, Jantina Mandelkow, Holger Till, Stephan Ehrhardt, Teunis A. Eggelte, Ulrich Bienzle

Research output: Contribution to journalArticle

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency confers protection against malaria in children, yet its role in malaria in pregnancy is unknown. In a cross-sectional study among 529 pregnant Ghanaian women, Plasmodium falciparum infection, anaemia and G6PD genotypes were assessed. Of these, 30.4% were heterozygous and 2.6% were homozygous for G6PD deficiency. The prevalence of P. falciparum infection decreased from 66% in G6PD-normal women to 58% in heterozygotes, and to 50% in individuals with homozygous G6PD deficiency (χtrend 2 = 4.4, P = 0.04). Multivariate analysis revealed that in multigravid women but not in primigravidae, heterozygous G6PD deficiency was associated with a reduced risk of P. falciparum infection (Odds ratio (OR), 0.6; 95% confidence interval (95% CI), [0.4-0.9]). This protection against infection was limited to the third trimenon of pregnancy. In addition, heterozygous G6PD deficiency was associated with a reduced risk of anaemia among infected multigravidae (OR, 0.5 [0.3-1.0]). Pregnancy is a period of high vulnerability to malaria. The results of this study provide evidence for protection against malaria in pregnancy caused by heterozygous G6PD deficiency. This advantage, even if confined to multigravid women, may contribute to the selection of G6PD variants in malaria-endemic regions.

Original languageEnglish (US)
Pages (from-to)118-124
Number of pages7
JournalTropical Medicine and International Health
Volume8
Issue number2
DOIs
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Glucosephosphate Dehydrogenase Deficiency
Plasmodium falciparum
Malaria
Anemia
Pregnant Women
Glucosephosphate Dehydrogenase
Pregnancy
Odds Ratio
Heterozygote
Multivariate Analysis
Cross-Sectional Studies
Genotype
Confidence Intervals

Keywords

  • G6PD deficiency
  • Malaria
  • Plasmodium falciparum
  • Pregnancy

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Parasitology
  • Immunology

Cite this

Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency. / Mockenhaupt, Frank P.; Mandelkow, Jantina; Till, Holger; Ehrhardt, Stephan; Eggelte, Teunis A.; Bienzle, Ulrich.

In: Tropical Medicine and International Health, Vol. 8, No. 2, 01.02.2003, p. 118-124.

Research output: Contribution to journalArticle

Mockenhaupt, Frank P. ; Mandelkow, Jantina ; Till, Holger ; Ehrhardt, Stephan ; Eggelte, Teunis A. ; Bienzle, Ulrich. / Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency. In: Tropical Medicine and International Health. 2003 ; Vol. 8, No. 2. pp. 118-124.
@article{772ea7c7a8254442859c51db43f0d1e4,
title = "Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency",
abstract = "Glucose-6-phosphate dehydrogenase (G6PD) deficiency confers protection against malaria in children, yet its role in malaria in pregnancy is unknown. In a cross-sectional study among 529 pregnant Ghanaian women, Plasmodium falciparum infection, anaemia and G6PD genotypes were assessed. Of these, 30.4{\%} were heterozygous and 2.6{\%} were homozygous for G6PD deficiency. The prevalence of P. falciparum infection decreased from 66{\%} in G6PD-normal women to 58{\%} in heterozygotes, and to 50{\%} in individuals with homozygous G6PD deficiency (χtrend 2 = 4.4, P = 0.04). Multivariate analysis revealed that in multigravid women but not in primigravidae, heterozygous G6PD deficiency was associated with a reduced risk of P. falciparum infection (Odds ratio (OR), 0.6; 95{\%} confidence interval (95{\%} CI), [0.4-0.9]). This protection against infection was limited to the third trimenon of pregnancy. In addition, heterozygous G6PD deficiency was associated with a reduced risk of anaemia among infected multigravidae (OR, 0.5 [0.3-1.0]). Pregnancy is a period of high vulnerability to malaria. The results of this study provide evidence for protection against malaria in pregnancy caused by heterozygous G6PD deficiency. This advantage, even if confined to multigravid women, may contribute to the selection of G6PD variants in malaria-endemic regions.",
keywords = "G6PD deficiency, Malaria, Plasmodium falciparum, Pregnancy",
author = "Mockenhaupt, {Frank P.} and Jantina Mandelkow and Holger Till and Stephan Ehrhardt and Eggelte, {Teunis A.} and Ulrich Bienzle",
year = "2003",
month = "2",
day = "1",
doi = "10.1046/j.1365-3156.2003.01008.x",
language = "English (US)",
volume = "8",
pages = "118--124",
journal = "Tropical Medicine and International Health",
issn = "1360-2276",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency

AU - Mockenhaupt, Frank P.

AU - Mandelkow, Jantina

AU - Till, Holger

AU - Ehrhardt, Stephan

AU - Eggelte, Teunis A.

AU - Bienzle, Ulrich

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Glucose-6-phosphate dehydrogenase (G6PD) deficiency confers protection against malaria in children, yet its role in malaria in pregnancy is unknown. In a cross-sectional study among 529 pregnant Ghanaian women, Plasmodium falciparum infection, anaemia and G6PD genotypes were assessed. Of these, 30.4% were heterozygous and 2.6% were homozygous for G6PD deficiency. The prevalence of P. falciparum infection decreased from 66% in G6PD-normal women to 58% in heterozygotes, and to 50% in individuals with homozygous G6PD deficiency (χtrend 2 = 4.4, P = 0.04). Multivariate analysis revealed that in multigravid women but not in primigravidae, heterozygous G6PD deficiency was associated with a reduced risk of P. falciparum infection (Odds ratio (OR), 0.6; 95% confidence interval (95% CI), [0.4-0.9]). This protection against infection was limited to the third trimenon of pregnancy. In addition, heterozygous G6PD deficiency was associated with a reduced risk of anaemia among infected multigravidae (OR, 0.5 [0.3-1.0]). Pregnancy is a period of high vulnerability to malaria. The results of this study provide evidence for protection against malaria in pregnancy caused by heterozygous G6PD deficiency. This advantage, even if confined to multigravid women, may contribute to the selection of G6PD variants in malaria-endemic regions.

AB - Glucose-6-phosphate dehydrogenase (G6PD) deficiency confers protection against malaria in children, yet its role in malaria in pregnancy is unknown. In a cross-sectional study among 529 pregnant Ghanaian women, Plasmodium falciparum infection, anaemia and G6PD genotypes were assessed. Of these, 30.4% were heterozygous and 2.6% were homozygous for G6PD deficiency. The prevalence of P. falciparum infection decreased from 66% in G6PD-normal women to 58% in heterozygotes, and to 50% in individuals with homozygous G6PD deficiency (χtrend 2 = 4.4, P = 0.04). Multivariate analysis revealed that in multigravid women but not in primigravidae, heterozygous G6PD deficiency was associated with a reduced risk of P. falciparum infection (Odds ratio (OR), 0.6; 95% confidence interval (95% CI), [0.4-0.9]). This protection against infection was limited to the third trimenon of pregnancy. In addition, heterozygous G6PD deficiency was associated with a reduced risk of anaemia among infected multigravidae (OR, 0.5 [0.3-1.0]). Pregnancy is a period of high vulnerability to malaria. The results of this study provide evidence for protection against malaria in pregnancy caused by heterozygous G6PD deficiency. This advantage, even if confined to multigravid women, may contribute to the selection of G6PD variants in malaria-endemic regions.

KW - G6PD deficiency

KW - Malaria

KW - Plasmodium falciparum

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0037332019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037332019&partnerID=8YFLogxK

U2 - 10.1046/j.1365-3156.2003.01008.x

DO - 10.1046/j.1365-3156.2003.01008.x

M3 - Article

C2 - 12581435

AN - SCOPUS:0037332019

VL - 8

SP - 118

EP - 124

JO - Tropical Medicine and International Health

JF - Tropical Medicine and International Health

SN - 1360-2276

IS - 2

ER -